SMARCA2 inhibitor therapy(Onco3R Therapeutics BV)

N/A

Report date: 2025/11/04 10:59:15
NME

Base Information

Drug NameSMARCA2 inhibitor therapy(Onco3R Therapeutics BV)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProbable global transcription activator SNF2L2 inhibitors
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnco3R Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesOnco3R Therapeutics BV
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A